Hims & Hers Health, Inc. (HIMS)
NYSE · Common · CUSIP 433000106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for HIMS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
433000106 (prev. G67789126 )
Market Cap
Mid Cap
IPO
7/18/2019
Previous Symbol
OAC (changed 1/21/2021)
Previous Name
Oaktree Acquisition Corp.
Business: Hims & Hers is a multi-specialty tele health platform that connects consumers to licensed health care professionals , enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primarycare,and more.
Notes: January 20, 2021 -- Hims & Hers Health, Inc. (“Hims & Hers”), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced that it has completed its business combination with Oaktree Acquisition Corp. (NYSE: OAC.U, OAC, OAC WS), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. (“Oaktree”). The transaction, which was approved on January 19, 2021 by Oaktree Acquisition Corp.’s shareholders, uniquely positions Hims & Hers to lead the rapidly-growing telehealth industry, with a focus on improving the customer experience from start to finish. Beginning January 21, 2021, Hims & Hers’ shares of Class A common stock will trade on the New York Stock Exchange (“NYSE”) under the symbol “HIMS” and its warrants will trade on the NYSE under the symbol “HIMS WS.

Company Contact

CEO
Andrew Dudum
CFO
Yemi Okupe
Headquarters
2269 Chestnut Street, #523 , San Francisco CA 94123
Phone
213-830-6300
Investor Relations
Bob East, ICR · 443-213-0500 · HIMSIR@westwicke.com
General Email
investors@forhims.com
SEC EDGAR Filings
View filings »
Find all related securities for HIMS »